GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Huapont Life Science Co Ltd (SZSE:002004) » Definitions » Cash, Cash Equivalents, Marketable Securities

Huapont Life Science Co (SZSE:002004) Cash, Cash Equivalents, Marketable Securities : ¥4,409 Mil (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Huapont Life Science Co Cash, Cash Equivalents, Marketable Securities?

Huapont Life Science Co's quarterly cash, cash equivalents, marketable securities declined from Sep. 2024 (¥4,235.60 Mil) to Dec. 2024 (¥3,943.60 Mil) but then increased from Dec. 2024 (¥3,943.60 Mil) to Mar. 2025 (¥4,408.74 Mil).

Huapont Life Science Co's annual cash, cash equivalents, marketable securities declined from Dec. 2022 (¥4,892.91 Mil) to Dec. 2023 (¥4,413.14 Mil) and declined from Dec. 2023 (¥4,413.14 Mil) to Dec. 2024 (¥3,943.60 Mil).


Huapont Life Science Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Huapont Life Science Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huapont Life Science Co Cash, Cash Equivalents, Marketable Securities Chart

Huapont Life Science Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,984.70 5,416.61 4,892.91 4,413.14 3,943.60

Huapont Life Science Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,901.93 4,399.41 4,235.60 3,943.60 4,408.74

Huapont Life Science Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Huapont Life Science Co  (SZSE:002004) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Huapont Life Science Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Huapont Life Science Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Huapont Life Science Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
Executives
Zhang Hai An Directors, executives
Wang Rong Director
Yu Jun Tian Director
Zhang Song Shan Directors, executives
Chen Zhi Securities Affairs Representative
Jiang Kang Wei Director
Lv Li Ming Director
Li Sheng Xue Director
Luo Da Lin Supervisors
Li Zhi Directors, executives
Tian Song Min Executives
Wu Bi Zhong Director
Yu Yun Jian Supervisors
Gu Chuan Wei Supervisors

Huapont Life Science Co Headlines

No Headlines